The global Duchenne muscular dystrophy (DMD) drugs market size was valued at USD 3.47 billion in 2023 and is projected to reach USD 9.91 billion by 2030, growing at a strong CAGR of 16.8% from 2024 to 2030. This rapid market expansion is primarily driven by the increasing prevalence of Duchenne muscular dystrophy (DMD), a rare but severe genetic disorder, along with the growing scope of genetic...